Distinct functional metagenomic markers predict the responsiveness to anti-pd-1 therapy in chinese non-small cell lung cancer patients

HIGHLIGHTS

• who: Chao Fang from the City University of Hong Kong, Hong Kong SAR, China have published the Article: Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients, in the Journal: Microbiome Help Predict NSCLC ICT
• what: This indicates that the contribution from specific functional pathways within the gut microbiota may shift rapidly in the PR group as compared to PD. The lack of lifestyle information in the real-life clinical setting of this study is a limitation, but still, the authors envisage that the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.